Synapse - Paul Hamlin

Results (293)

Effect of prednisone and rituximab prephase on early toxicity in older DLBCL patients (pts) receiving RCHOP within a NHL specific comprehensive geriatric assessment (CGA) trial

Meeting Abstract

Owens, C. N.; Iannotta, A.; Gerecitano, J. F.; Matasar, M. J.; Noy, A.; Moskowitz, C. H.; Drullinsky, P.; Palomba, M. L.; Straus, D. J.; Horwitz, S. M.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

A phase I/II trial of the combination of romidepsin and lenalidomide in patients with relapsed/refractory lymphoma and myeloma: Activity in T-cell lymphoma

Meeting Abstract

Mehta-Shah, N; Lunning, M. A.; Boruchov, A. M.; Ruan, J.; Nair, S.; Lynch, P.; Byrne, R.; Moskowitz, A. J.; Matasar, M. J.; Gerecitano, J. F.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Phase 1 open-label dose escalation study of the dual SYK/JAK inhibitor cerdulatinib (PRT062070) in patients with relapsed/refractory B-cell malignancies: Safety profile and clinical activity

Meeting Abstract

Flinn, I.; Hamlin, P. A.; Strickland, D. K.; Pandey, A.; Birrell, M.; Coffey, G.; Leeds, J.; Curnutte, J. T.; Burger, J. A.; Wagner-Johnston, N. D.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

High-dose chemotherapy and autologous stem cell transplant in older patients with lymphoma

Journal Article

Lahoud, O. B.; Sauter, C. S.; Hamlin, P. A.; Dahi, P. B.
Current Oncology Reports (2015)

Fulltext@MSK | Save

Approach to therapy of diffuse large B-cell lymphoma in the elderly: The International Society of Geriatric Oncology (SIOG) expert position commentary

Journal Article

Morrison, V. A.; Hamlin, P.; Soubeyran, P.; Stauder, R.; Wadhwa, P.; Aapro, M.; Lichtman, S. M.
Annals of Oncology (2015)

Fulltext@MSK | Save

Diffuse large B-cell lymphoma in the elderly: Impact of prognosis, comorbidities, geriatric assessment, and supportive care on clinical practice. An International Society of Geriatric Oncology (SIOG) expert position paper

Journal Article

Morrison, V. A.; Hamlin, P.; Soubeyran, P.; Stauder, R.; Wadhwa, P.; Aapro, M.; Lichtman, S.
Journal of Geriatric Oncology (2015)

Fulltext@MSK | Save

PET-adapted sequential salvage therapy with brentuximab vedotin followed by augmented ifosamide, carboplatin, and etoposide for patients with relapsed and refractory Hodgkin's lymphoma: A non-randomised, open-label, single-centre, phase 2 study

Journal Article

Moskowitz, A. J.; Schöder, H.; Yahalom, J.; Mccall, S. J.; Fox, S. Y.; Gerecitano, J.; Grewal, R.; Hamlin, P. A.; Horwitz, S.; Kobos, R.; more...
Lancet Oncology (2015)

Fulltext@MSK | Save

Phase I/II trial of vorinostat with rituximab, cyclophosphamide, etoposide and prednisone as palliative treatment for elderly patients with relapsed or refractory diffuse large B-cell lymphoma not eligible for autologous stem cell transplantation

Journal Article

Straus, D. J.; Hamlin, P. A.; Matasar, M. J.; Lia Palomba, M.; Drullinsky, P. R.; Zelenetz, A. D.; Gerecitano, J. F.; Noy, A.; Hamilton, A. M.; Elstrom, R.; more...
British Journal of Haematology (2015)

Fulltext@MSK | Save

Personalizing therapy for older adults with lymphoid malignancies: Options and obstacles

Journal Article

Wildes, T. M.; Goede, V.; Hamlin, P.
American Society of Clinical Oncology Educational Book (2014)

Fulltext@MSK | Save

A phase I/II trial of the combination of romidepsin and lenalidomide in patients with relapsed/refractory lymphoma and myeloma: Phase I results

Meeting Abstract

Lunning, M. A.; Ruan, J.; Nair, S.; Boruchov, A. M.; Byrne, R.; Gerecitano, J. F.; Hamlin, P. A.; Inserra, B.; Leonard, J.; Lynch, P.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save